Yersinia Pestis F1 Antigen, Antibody

Cat.# 3YP8

This data sheet is provided for information only. After adding the product to the cart by clicking the button below you will see if there is a volume discount available.

Sign up or login to see prices and to request offers

MAb: YPF19
Price:
-- / mg
Login for price
* All prices excluding VAT
Request an offer Samples available
Biodefense
  • Cat.#

    3YP8

  • MAbs:

    YPF19

    Hybridoma clone has been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunised with purified F1 antigen from Y. pestis vaccine strain EV.

  • Specificity:

    Y. pestis

    MAb YPF19 reacts with capsule-bearing strains of Y. pestis only.

  • MAb isotypes:

    IgG1 for MAb YPF19

  • Applications:

    Detection of Y. pestis in ELISA and Western blotting. MAb works in immunohistochemistry.

  • Purification:

    Protein G chromatography

  • Presentation:

    PBS, pH 7.4, 0.09 % sodium azide (NaN₃)

  • Storage:

    +4 °C (+2 … +8 °C allowed)

  • Material safety note:

    This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.

    Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.

×

Bulk Price Quotation

You can request quotations by filling in the desired amount and your information. Please note that if you register or login you can see the prices immediately without waiting for quotes. You can also request a sample here.

Yersinia Pestis F1 Antigen, Antibody (MAb: )

Information

×

Sample Request

Yersinia Pestis F1 Antigen, Antibody (MAb: )

Evaluation samples available. You can save up to 50%*

Information

*The usual shipping and handling costs will still apply. The sample opportunity is a one-time evaluation possibility and you can get more details by contacting HyTest customer service.

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!